​

Coherus Oncology Ownership | Who Owns Coherus Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Coherus Oncology Ownership Summary


Coherus Oncology is owned by 52.46% institutional investors, 19.12% insiders, and 28.42% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.96% of its assets in Coherus Oncology shares.

CHRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoherus Oncology52.46%19.12%28.42%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.75M10.42%$20.33M
Blackrock funding, inc. /de12.00M8.80%$16.80M
Vanguard group10.03M8.63%$14.24M
Vanguard capital management5.95M4.36%$8.33M
Geode capital management3.69M2.70%$5.16M
Samsara biocapital3.43M2.51%$4.80M
Kohlberg kravis roberts3.04M2.23%$4.18M
State street2.38M1.75%$3.34M
Two sigma investments, lp2.26M1.66%$3.16M
Cm management2.10M1.54%$2.94M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management2.10M1.87%$2.94M
Samsara biocapital3.43M0.39%$4.80M
Pvg asset management133.24K0.11%$186.53K
Kohlberg kravis roberts3.04M0.07%$4.18M
C worldwide group1.93M0.07%$2.70M
Spark investment management17.80K0.05%$24.92K
Tyche wealth partners201.20K0.04%$281.68K
Gsa capital partners llp379.36K0.03%$531.00K
State of wyoming119.27K0.02%$164.59K
Canton hathaway58.23K0.02%$81.52K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de12.00M0.00%1.64M
Sixth street partners management company1.23M0.00%1.23M
Jacobs levy equity management1.00M0.01%1.00M
Geode capital management3.69M0.00%563.99K
Blackrock11.75M0.00%521.98K

Top Sellers

HolderShares% AssetsChange
Temasek (private)---5.82M
Point72 asset management---5.28M
Tang capital management---1.89M
Propel bio management---1.42M
Macquarie group---900.00K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.23M0.00%1.23M$1.72M
Norges bank491.50K0.00%491.50K$850.29K
Canton hathaway58.23K0.02%58.23K$81.52K
Entrypoint capital24.38K0.01%24.38K$34.13K
Curated wealth partners20.00K0.00%20.00K$22.36K

Sold Out

HolderChange
Wealth preservation advisors-8.00
Eagle bay advisors-30.00
Nelson, van denburg & campbell wealth management group-31.00
Larson financial group-40.00
Cornerstone planning group-49.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026150-6.83%71,553,85620.72%522.78%74-18.68%4117.14%
Mar 31, 202615521.09%58,795,69014.78%482.51%8738.10%356.06%
Dec 31, 202578-34.45%37,433,194-27.54%321.63%37-32.73%19-42.42%
Sep 30, 202558-48.67%31,871,888-42.43%271.21%22-51.11%21-41.67%
Jun 30, 2025113-4.24%55,361,532-10.83%471.66%46-6.12%35-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.43M2.96%-
Vanguard Morn Total Stk Mkt Idx Investor3.95M2.56%324.20K
Vanguard Total Stock Mkt Idx Inv3.95M2.56%324.20K
Vanguard MStar Total Stk Mkt Idx Invest3.95M2.56%-
HBM Healthcare Investments AG Ord3.71M2.41%-
iShares Russell 2000 ETF3.15M2.04%-55.87K
C WorldWide Healthcare Select 1A1.93M1.25%-
Vanguard Institutional Extnd Mkt Idx Tr1.79M1.16%-71.43K
Vanguard Strategic Equity Inv1.58M1.06%-
Vanguard Explorer Inv1.57M1.05%-

Recent Insider Transactions


DateNameRoleActivityValue
May 23, 2025Wahlstrom Mats-Sell$73.88K
Nov 22, 2023Lanfear Dennis M President & CEOSell$449.77K
Oct 15, 2021Stilwell McDavid Chief Financial OfficerSell$58.92K
Sep 28, 2021HEALY JAMES-Sell$829.81K
Sep 27, 2021HEALY JAMES-Sell$1.81M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2-1
2025 Q1--
2024 Q4--
2024 Q3--

CHRS Ownership FAQ


Who Owns Coherus Oncology?

Coherus Oncology shareholders are primarily institutional investors at 52.46%, followed by 19.12% insiders and 28.42% retail investors. The average institutional ownership in Coherus Oncology's industry, Biotech Stocks , is 380.48%, which Coherus Oncology falls below.

Who owns the most shares of Coherus Oncology?

Coherus Oncology’s largest shareholders are Blackrock (11.75M shares, 10.42%), Blackrock funding, inc. /de (12M shares, 8.80%), and Vanguard group (10.03M shares, 8.63%). Together, they hold 27.85% of Coherus Oncology’s total shares outstanding.

Does Blackrock own Coherus Oncology?

Yes, BlackRock owns 10.42% of Coherus Oncology, totaling 11.75M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.33M$. In the last quarter, BlackRock increased its holdings by 521.98K shares, a 4.65% change.

Who is Coherus Oncology’s biggest shareholder by percentage of total assets invested?

Cm management is Coherus Oncology’s biggest shareholder by percentage of total assets invested, with 1.87% of its assets in 2.1M Coherus Oncology shares, valued at 2.94M$.

Who is the top mutual fund holder of Coherus Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Coherus Oncology shares, with 2.96% of its total shares outstanding invested in 3.43M Coherus Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools